Clinical Trial: Prospective Comparison of Ampicillin / Amoxicillin Versus Ceftriaxone for the Treatment of Salmonella Infections in AIDS Patients

This study has been completed.

Sponsored by: University of Southern California
Information provided by: AIDS Clinical Trials Information Service

Purpose

To compare the effectiveness of standard treatment with parenteral ampicillin and oral amoxicillin compared to initial daily therapy with ceftriaxone followed by 3 times weekly suppressive treatment for salmonella infections in AIDS patients.

Condition Treatment or Intervention
HIV Infections
Salmonella Infections
 Drug: Ceftriaxone sodium
 Drug: Ampicillin sodium
 Drug: Amoxicillin trihydrate

MedlinePlus related topics:  AIDS;   Salmonella Infections

Study Type: Interventional
Study Design: Treatment, Dose Comparison

Eligibility

Ages Eligible for Study:  18 Years and above,  Genders Eligible for Study:  Both

Criteria

Exclusion Criteria

Co-existing Condition: Patients with the following are excluded:

Patients with the following are excluded:

Prior Medication: Excluded within 48 hours of study entry:

HIV infection, AIDS, or AIDS related complex (ARC).

  • Salmonella bacteremia or positive stool culture in patient with 3 or more stools per day.

Location Information


California
      Los Angeles County - USC Med Ctr, Los Angeles,  California,  90033,  United States

More Information

Study ID Numbers:  019A
Record last reviewed:  August 1989
Last Updated:  October 13, 2004
Record first received:  November 2, 1999
ClinicalTrials.gov Identifier:  NCT00002052
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08


Source: ClinicalTrials.gov
Cache Date: April 9, 2005

Resources